An Investigation by Adam White WattyAlan Reports. Town’s Disease Series, Part One

You walk into a consulting room. You describe your symptoms. A clinician runs tests, reviews results, and delivers a diagnosis. You leave with a name for your condition.

That name tells you nothing about what caused it. Nothing about how to stop it progressing. In many cases, nothing about the condition at all. It tells you where the condition was first observed, or who first wrote it up, or what the symptoms look like from the outside. You have not received an explanation. You have received a label. And in a significant number of cases, that label is the reason the explanation will never arrive.

This is not a stylistic complaint about medical terminology. It is a structural analysis of how naming conventions determine which questions get asked, which research gets funded, and which patients get told their condition is incurable, when what has failed is the institutional habit of looking at the endpoint instead of the origin.

A Classification Error Built Into the Grammar

“I have Alzheimer’s disease.” “I have Parkinson’s disease.” “I have coeliac disease.” Notice the grammar. Possessive. As though the condition arrived as a finished product rather than developing through a sequence of identifiable upstream events.

If a condition is an entity, the clinical task is to characterise it: what does it look like, how does it progress, which proteins are involved, which drug targets exist. If a condition is an outcome of identifiable upstream processes, the clinical task shifts entirely: identify the upstream cause, remove it, and assess the damage. One framing produces chronic disease management. The other produces prevention and, where damage is not yet irreversible, recovery.

Medical nomenclature overwhelmingly describes three things: what a condition looks like, where it was first observed, or who first described it. Almost never does it describe what is mechanistically happening or why.

Eponymous names. Parkinson’s, Alzheimer’s, Crohn’s, Addison’s, Hodgkin’s. A patient carries a doctor’s surname. Historical credit is encoded. Mechanistic information is absent. A Parkinson’s diagnosis tells you that James Parkinson described these symptoms in 1817. It does not communicate that substantia nigra neurons are dying from a specific biochemical cascade with identifiable upstream triggers, some of which may be modifiable.

Geographic names. Lyme disease, Ebola, Marburg, Zika, West Nile. Linguistically, the patient is infected with a place. Nothing about the pathogen, the mechanism of injury, or the route of exposure survives into the name.

Descriptive names. Diabetes mellitus (sweet urine), lupus (wolf-like rash), influenza (influence of the stars). At least an attempt at description, but of the downstream symptom rather than the upstream cause. Sweet urine does not explain why pancreatic beta cells failed.

In every category, the name encodes the presentation rather than the process, the endpoint rather than the origin. And because medicine organises its entire institutional apparatus around these names (research funding categories, pharmaceutical pipeline targets, clinical specialty boundaries, patient advocacy structures), the name does not merely describe. It determines what questions are asked.

Lyme: The Assumption Cascade

Lyme disease is the cleanest demonstration of the naming problem because every component of the failure is visible, from the laboratory down to the consulting room.

In 1975, a cluster of juvenile arthritis cases appeared in Lyme, Connecticut. In 1981, Willy Burgdorfer identified the causative organism: a spirochetal bacterium, now called Borrelia burgdorferi. An organism was identified. A mechanism was documented. And then the condition was named after a town.

Consider what happens next, not in the laboratory but in a GP surgery, a walk-in clinic, or a hospital admission. A patient presents feeling unwell. They mention a tick bite. A clinician reaches for the label.

Here is where isolation should win. It almost never does.

A tick bite and feeling unwell do not constitute a diagnosis of spirochetal infection. A tick bite is one event. Feeling unwell is a state with dozens of possible explanations. Between those two data points lies a diagnostic gap that the name “Lyme disease” fills without evidence. You might have consumed contaminated food on the same day. You might have a compromised gut lining, what practitioners call leaky gut, through which bacteria from routine dietary exposure have entered the bloodstream. You might have eaten organic lettuce carrying Escherichia coli, an organism that undergoes binary fission every forty minutes and, once it crosses the gut barrier into the blood, causes direct red blood cell damage. Oxygen-carrying capacity drops. Energy plummets. You feel terrible.

Meanwhile, all clinical attention is on the tick bite. Assumptions are made. A label is assigned. And in many cases, that label is held as an identity for a lifetime, while nobody bothered to look.

Looking means putting blood under a microscope. Not running a culture. Not waiting for serology panels. Direct observation. A spirochete in human blood is a visible, identifiable organism. So is Staphylococcus. So is Streptococcus. So is E. coli. Direct microscopy identifies what is present in the blood in front of you, in real time, without the diagnostic lag of culture-based methods and without the interpretive ambiguity of serology that measures immune response rather than confirming the presence of the organism itself.

And once the organism is identified by direct observation, the treatment follows the identification. Anti-parasitical intervention, a ferricyanide salt for instance, can eliminate observable organisms faster than any antibiotic course, with confirmation of clearance under the same microscope that identified the problem. Identification, treatment, and verification in a single clinical sequence, tied to what is observed rather than what is assumed.

This is not how the system operates. Under the naming convention, a tick bite plus malaise equals “Lyme disease,” and the label generates its own treatment protocol regardless of whether anyone confirmed the presence of the organism it supposedly describes.

What the Name Creates

“Lyme disease” creates a bounded diagnostic category that feels specific when the underlying reality is a spectrum. Some patients develop a localised skin reaction that resolves. Some develop multi-system inflammatory damage that persists for years. Calling both by the same name collapses this spectrum into a single entity with a single treatment protocol and a single expected outcome, which then creates a clinical absurdity:

A patient has a confirmed Borrelia burgdorferi infection. Anti-parasitical treatment eliminates the spirochete. But the infection caused tissue damage, neurological, articular, cardiac, that persists after the organism is gone. A clinician says: you no longer have Lyme disease. A patient says: then why am I still symptomatic?

Once the name is “cured,” the ongoing damage is orphaned. No diagnostic category. No billing code. No research stream. Residual tissue damage, the clinical problem that matters most to the patient, falls into a gap between infectious disease (which considers its job done) and neurology or rheumatology (which were never involved because the condition was categorised as an infection, not an injury).

What a Clinical Conversation Reveals

Here is what this looks like in practice, drawn from repeated clinical experience with live blood microscopy.

A patient presents. “I have Lyme disease. I’ve had it for ten years.”

You place a drop of their blood under a microscope. You show them what a spirochete looks like in human blood: the characteristic corkscrew morphology, the motility pattern. Then you show them their own blood.

“Do you see any of these in your blood?”

“No. There are none of those in my blood, are there?”

“Correct. There are no spirochetes in your blood.”

“But I’ve got Lyme disease. I’ve had it for ten years.”

“When you were bitten by the tick, did anyone identify spirochetes in your blood? Or is this the first time you have heard the word spirochete?”

“Never heard of them. My doctor said if I’d been bitten by a tick and I didn’t feel well, it might be Lyme disease.”

“You do not have Lyme disease. Lyme is the name of a town. You cannot be infected with a postcode, and a postcode cannot be treated.”

“Then why do I feel terrible?”

“What does your diet consist of?”

And there, in the silence that follows, the investigation begins for the first time. Ten years after a label was assigned and never questioned.

What a Mechanistic Diagnosis Looks Like

Strip the geographic label and the diagnostic sequence becomes clear:

1. Identify what is present. Direct microscopy of blood, looking for spirochetes, bacteria, parasites, or other observable organisms.

2. Confirm or exclude infection. If spirochetes are present, infection is confirmed. If absent, the label is wrong and the investigation must broaden.

3. Map the tissue damage. Neurological, articular, cardiac, dermatological. Which tissues are injured, to what extent, and what is the current functional status.

4. Treat the organism and the injury as separate problems. Anti-parasitical intervention for the pathogen. System-by-system assessment and rehabilitation for the tissue damage.

5. Investigate alternative causation. Dietary exposure, gut barrier integrity, bacterial translocation, parasitic load from sources unrelated to tick bite. Confirm through observation, not assumption.

Under this framework, “Lyme disease” dissolves. It becomes: spirochetal infection (Borrelia burgdorferi), confirmed or excluded by direct microscopy, with secondary tissue injury assessed and addressed system by system, and alternative upstream causes investigated where spirochetal infection is absent. Every word in that description points toward a specific clinical action. “Lyme disease” points toward a town in Connecticut.

Pellagra: When the Name Dissolved, the Condition Disappeared

Pellagra was classified as a disease for decades. It had clinical criteria (the four Ds: dermatitis, diarrhoea, dementia, death). It had an institutional apparatus. It had competing theories of causation: infection, toxin exposure, genetic susceptibility. It had patients who were told they “had pellagra” as though pellagra existed independently of the conditions that produced it.

In 1914, Joseph Goldberger began demonstrating that pellagra was caused by niacin deficiency. His work was resisted for over a decade because the disease model was entrenched. Research communities had formed. Diagnostic criteria were established. Dissolving the category threatened all of it.

Goldberger was right. Pellagra was not a disease. It was an injury from inadequate niacin intake. Once the deficiency was identified and corrected, the condition ceased to exist. Not because a drug was developed. Not because a treatment protocol was optimised. The condition ceased to exist because a mechanistic understanding replaced a name, and made prevention trivial.

Before Goldberger: pellagra is a complex, mysterious disease requiring institutional investigation.

After Goldberger: niacin deficiency produces predictable tissue damage, correctable by dietary repletion.

Nothing about the condition changed. What dissolved was the framing. And the framing change is what made it preventable.

Scurvy: Evidence Ignored for Decades Because the Name Held

James Lind published his controlled trial on citrus fruit and scurvy in 1753. Sailors had been dying from the condition for hundreds of years before that, and continued dying for decades after Lind’s publication, because naval medicine could not reorganise around a dietary explanation for a condition it had classified as a disease.

Scurvy was ascorbic acid deficiency. Gum deterioration, skin lesions, old wounds reopening, haemorrhage. Every symptom was traceable to collagen synthesis failure caused by the absence of a single micronutrient. Every symptom was reversible by correcting the deficit, provided the damage had not progressed beyond recovery.

Lind’s evidence was available. Institutional action did not follow. The delay cost tens of thousands of lives. Not because of insufficient evidence, but because a name had created the expectation of a disease-model investigation: identify the entity, characterise it, develop treatments. As soon as scurvy was recognised as a dietary injury, the investigation was over and the prevention was obvious.

What Naming Obscures

Occam’s razor applied to the diagnostic landscape asks a question that the current naming convention cannot tolerate: how many conditions currently classified as discrete diseases are distinguishable injury patterns from a smaller number of upstream causes, given different names because they were observed in different tissues, at different stages, by different specialists?

Beriberi was thiamine deficiency. Scurvy was ascorbic acid deficiency. Pellagra was niacin deficiency. Rickets was vitamin D deficiency. Four “diseases,” each with its own diagnostic criteria, research community, and clinical infrastructure. One upstream category: micronutrient injury from inadequate dietary intake. Four names obscured the simplicity of the cause by insisting on the complexity of the presentation.

“Dropsy” was a symptom diagnosis, fluid retention, that collapsed heart failure, kidney failure, and liver disease into a single category. Dissolving the name into mechanistic components was what allowed specific treatment of each underlying cause. In that case, the name was an active barrier to correct diagnosis.

Modern Diagnostic Vocabulary: Endpoints Without Origins

A patient diagnosed with “Type 2 diabetes” is told they have a disease characterised by insulin resistance and elevated blood glucose. A metabolic endpoint is described. An upstream process is not. What caused the insulin resistance? Chronic hyperinsulinaemia from decades of refined carbohydrate consumption? Mitochondrial dysfunction from lipid peroxidation? Adipose tissue inflammation from chronic caloric excess? Each upstream cause has a different optimal intervention. A single label treats them as one condition with one protocol.

A patient diagnosed with “essential hypertension” is told they have high blood pressure with no identifiable cause. In medical terminology, “essential” means the cause is unknown. A measurement combined with an admission of ignorance. Lifelong antihypertensive medication manages the measurement while the name provides justification for never investigating further.

A patient diagnosed with “irritable bowel syndrome” is told they have a syndrome, a cluster of symptoms, affecting their bowel. Words that describe what the patient already knew before they walked into the consulting room, with “syndrome” appended to create the appearance of a defined clinical entity. Food sensitivities, dysbiosis, bile acid malabsorption, visceral hypersensitivity, mast cell activation, small intestinal bacterial overgrowth. Each mechanistically distinct, each requiring different investigation and intervention. A single label wrapping them all discourages differential investigation.

Three Categories the Word “Disease” Obscures

If the naming convention were rebuilt from first principles, conditions currently labelled as “diseases” would fall into three categories:

Injury from identifiable exposure. Nutritional, chemical, environmental, or radiation injury where tissue damage is the downstream consequence of exposure to a specific agent or deficiency of a specific substance. Identify the exposure, cease it, assess the damage, and support recovery system by system. Many conditions labelled as chronic diseases belong here.

Infection by a specific organism. Bacterial, viral, fungal, or parasitic infection where the pathogen is identifiable, ideally by direct observation under microscopy, and tissue damage is the consequence of the organism’s activity and the immune response to it. Identify and eliminate the organism through targeted anti-parasitical intervention, then assess and treat residual tissue damage as a separate clinical problem. Confirm clearance by the same method that confirmed presence.

Genetic structural variation. Conditions arising from inherited or de novo genetic mutations that alter cellular structure or function. Identify the specific genetic variant, understand the mechanistic consequence, and manage downstream effects with reference to the biology rather than to a discoverer’s surname.

“Disease” collapses all three into a single conceptual category implying that you have caught or developed a discrete entity, which must be fought, managed, or endured. That framing serves pharmaceutical intervention models. It serves patients and prevention poorly.

What the Name Costs

Research funding flows to the wrong targets. Clinical protocols manage symptoms instead of investigating causes. Patients are told their condition is incurable when what has failed is the institutional commitment to a label that was never a diagnosis. Prevention strategies are never developed because the naming convention defines a condition as something to be treated rather than something to be traced upstream and eliminated.

Pellagra killed people until the name was dissolved. Scurvy killed people for decades after the cause was identified. In both cases, the delay between evidence and action was mediated by a naming convention that substituted a label for an investigation.

How many conditions labelled as diseases today are waiting for their Goldberger? How many patients are carrying a town’s name as a diagnosis while nobody has put their blood under a microscope?

When a clinician delivers a diagnosis, two questions determine whether you have received information or been filed:

What is the mechanism causing this?

And does the name tell me anything about it?

If the answer to the second question is no, the name is not a diagnosis. It is a filing system. And filing systems are administrative conveniences, not explanations.

“Doc, am I infected with a town?”

“No. But before I tell you what you have, I need to look at what is in your blood. Not guess. Not assume. Not infer from a tick bite. Look.”

“And if there are no spirochetes?”

“Then we widen the investigation. What have you eaten? What is the state of your gut lining? What organisms are present that should not be? Direct observation first. Diagnosis second. Name last, if at all.”

“My last doctor gave me the name first.”

“And in ten years, did anyone look?”

“No.”

“Then you have never been diagnosed. You have been labelled. And the label stopped everyone, including you, from asking the question that matters: what is mechanistically wrong, and what does your blood show?”

WattyAlan Reports. Town’s Disease Series, Part One. Adam White.

Summary

In 1931, Abner Wolf and Alwin Pappenheimer at Columbia University documented a disease they called nutritional encephalomalacia in chicks.¹ The mechanism was simple: high polyunsaturated fatty acid intake, combined with inadequate vitamin E and selenium, triggered lipid peroxidation in brain tissue. The peroxidation caused capillary dysfunction. The capillary dysfunction caused localised ischemia. The ischemia caused the brain to soften. The chicks lost coordination, lost normal behaviour, and died.

Ninety-five years later, the same biochemical pathway is operating in human food systems at industrial scale.

This report traces the documented chemistry from ready meal production line to human neurodegenerative disease. It does not speculate. Every claim is grounded in published research, verified biochemical pathways, or observable industrial practice. The conclusion is uncomfortable but unavoidable: what we call Alzheimer’s, Parkinson’s, vascular dementia, and “mixed dementia” are, in significant part, regional expressions of the same upstream nutritional injury that killed those chicks in 1931.

The mechanism never changed. The species did.

Part One: The Pathway

1.1 Wolf and Pappenheimer, 1931

Abner Wolf and Alwin Pappenheimer published their histopathology of nutritional encephalomalacia at the College of Physicians and Surgeons, Columbia University, New York. The paper was received on 22 May 1931 and published in the Journal of Experimental Medicine.¹ Their findings were precise and their language was clinical, but the implications were devastating. They described a disease produced entirely by dietary composition.

Chicks fed diets high in polyunsaturated fatty acids with inadequate vitamin E and selenium developed cerebellar lesions. The earliest lesions pointed very definitely to a circulatory disturbance as the initial factor, not direct toxic injury and not infection. Capillary engorgement, endothelial swelling, and vasomotor paralysis preceded tissue necrosis. The blood supply to the brain failed before the brain cells died.

The sequence they documented was meticulous:

First, pial vessel engorgement and capillary dilation, with some vessels empty and others engorged, indicating vasomotor instability. Then mild edema separating the neural fibres. Then Purkinje cells losing their Nissl substance, becoming angular, their nuclei pyknotic. Hyaline capillary thrombi forming in and around necrotic areas. Microglial rod cells arranging along Purkinje cell dendrites in a process called neuronophagia, the brain’s immune cells consuming its own neurons. Compound granule cells, lipid-laden phagocytes staining positive with Scharlach R, invading the damaged tissue to scavenge the debris. Finally, mesodermal organisation, reticular fibre ingrowth, and tissue softening: encephalomalacia.

Their most striking observation: the original paper documents that most extreme changes may develop in a very short period, certainly within six hours or less.

Six hours. From feed exposure to measurable brain damage. Wolf and Pappenheimer demonstrated that nutritional imbalance alone, without any viral, bacterial, or toxic agent, produced acute brain injury through a purely metabolic mechanism. The brain did not need to be infected. It needed to be fed the wrong fats without adequate protection.

A companion paper by Pappenheimer and Goettsch, published the same year in the same journal, established the cerebellar specificity and dietary aetiology of the condition.²

1.2 The Biochemistry Is Not Species-Specific

The pathways Wolf and Pappenheimer documented are evolutionarily conserved across all vertebrates. They are not peculiarities of avian neurology. They are fundamental features of how brains work.

Vitamin E (alpha-tocopherol) functions identically in chick, mammalian, and human brains. It sits within neuronal membrane lipid bilayers and intercepts lipid peroxyl radicals before they can propagate chain reactions through the membrane. Without vitamin E, a single oxidative event in one fatty acid molecule triggers a cascade that can destroy thousands of neighbouring molecules. The chain reaction is self-sustaining once vitamin E is depleted.

Selenium-dependent glutathione peroxidase operates via the same enzymatic mechanism across species. It converts lipid hydroperoxides, the primary products of fatty acid oxidation, into harmless alcohols using reduced glutathione as a cofactor. When selenium is deficient, this enzyme cannot function. Lipid hydroperoxides accumulate, decompose into toxic secondary products (4-HNE, MDA, acrolein), and the damage compounds.

Linolenic acid oxidation is a matter of physics, not biology. A linolenic acid molecule contains three double bonds. Each double bond is a site where molecular oxygen can attack the carbon chain. The relative autoxidation rates of fatty acids have been established in food chemistry: stearic acid (saturated, no double bonds) at 1, oleic acid (one double bond) at 100, linoleic acid (two double bonds) at 1,200, and linolenic acid (three double bonds) at 2,500.³ This rate difference is a property of chemical bond geometry, specifically the number of bis-allylic methylene positions available for hydrogen abstraction. It does not change between chick and human. It does not change between a Columbia University laboratory and a ready meal factory.

When both defences, vitamin E and selenium-dependent glutathione peroxidase, fail simultaneously, the outcome is identical in any vertebrate: lipid peroxidation becomes self-sustaining, capillary endothelium swells, regional blood flow collapses, and neural tissue dies.

Subscribe now

1.3 The Human Clinical Equivalents

Humans absolutely develop the same disease. The terminology differs because human medicine names conditions by clinical presentation and affected anatomy rather than underlying mechanism:

Chick Terminology Human Clinical Equivalent Shared Mechanism Nutritional encephalomalacia Ataxia with Vitamin E Deficiency (AVED)Lipid peroxidation, cerebellar Purkinje cell loss Cerebellar haemorrhage and edema Sensory ataxia, areflexia, proprioceptive loss Oxidative damage to neuronal membranes Capillary thrombi, ischemic necrosis Progressive neurodegeneration in fat-malabsorption syndromes Vascular and oxidative injury cascade

AVED is a documented autosomal recessive disorder caused by mutations in the TTPA gene, which impairs hepatic alpha-tocopherol transfer protein function. Patients present with progressive ataxia, loss of reflexes, and cerebellar degeneration. The histopathology is analogous to the chick model. The mechanism is identical: inadequate vitamin E delivery to neural tissue permits lipid peroxidation to destroy cerebellar neurons.

Humans with cystic fibrosis, abetalipoproteinemia, or short bowel syndrome develop identical neurological syndromes when vitamin E status is not aggressively supplemented. In every case, the disease follows fat-soluble vitamin malabsorption. The brain requires vitamin E to protect its membranes. When the supply fails, the membranes oxidise, the capillaries swell, and the tissue softens.

The condition exists in humans. It is documented. It is real. The question is not whether the mechanism can operate in people. It is whether modern diets are producing it at population scale without anyone recognising what they are looking at.

1.4 Why the Term “Encephalomalacia” Is Rarely Used in Human Adults

The term encephalomalacia describes a pathological endpoint: softening of brain tissue. In human medicine, it appears primarily in paediatric cases and post-stroke assessments. Adult trauma case reports note that encephalomalacia is not frequently described in the literature, with most research focusing on infants and children, and rarely on the adult population. When described in adults, encephalomalacia is most commonly associated with a cerebrovascular event.

This creates a diagnostic blind spot. When a 70-year-old presents with progressive cognitive decline and MRI shows hippocampal atrophy and white matter changes, the clinician reaches for “Alzheimer’s disease” or “vascular dementia.” The possibility that the brain tissue has softened due to chronic nutritional injury via functional capillary disturbance is not considered because the term encephalomalacia is not in the clinician’s differential diagnosis vocabulary for adult-onset neurological disease.

Nutritional encephalomalacia produces identical histopathology to ischemic stroke encephalomalacia. Without dietary history and antioxidant status measurement, the two are indistinguishable at post-mortem. The cause is different. The endpoint is the same. And the endpoint is what gets recorded.

Part Two: The Ready Meal

2.1 Composition Profile

A typical UK ready meal (2024–2026) contains the following:

Component Specification Significance Primary cooking oil Rapeseed/sunflower blend Cost-driven substitution, accelerated post-2022Omega-6 content15–25g per meal Linoleic acid dominantOmega-3 content Less than 0.5g per meal Minimal ALA, zero EPA/DHA Vitamin E1–3mg (10–20% RDA)Stripped during refiningSelenium5–15mcg (10–25% RDA)Soil depletion and processing loss Processing history Pre-cooked, chilled or frozen, reheated3–4 thermal oxidation cycles minimum

The oil chemistry is the critical variable. Rapeseed oil contains 20–25% linolenic acid, the fatty acid that autoxidises 2,500 times faster than saturated fat.³ Sunflower oil (high-linoleic varieties) contains 65–70% linoleic acid, which autoxidises 1,200 times faster. Both oils are refined at 200–230°C, bleached, and deodorised before they reach the food manufacturer. This refining process strips the majority of native tocopherols that would otherwise provide some protection against oxidation. The oils arrive at the factory pre-oxidised and largely defenceless.

2.2 The Thermal Abuse Timeline

A ready meal undergoes multiple heating cycles before consumption. Each cycle multiplies the concentration of toxic degradation products:⁴⁵

Cycle 1: Industrial cooking. Oil heated to 160–190°C during manufacturing. Linolenic and linoleic acid begin fragmenting. 4-hydroxy-2-nonenal (4-HNE), malondialdehyde (MDA), acrolein, hexanal, and 2,4-decadienal form. Native tocopherols are further depleted.

Cycle 2: Packaging and distribution. Ongoing ambient oxidation during chilling, transport, warehouse storage, and retail shelf life. The oil continues to degrade at room temperature. Peroxide values rise steadily. The “best before” date addresses microbial safety, not lipid oxidation status.

Cycle 3: Consumer reheating. Microwave or oven, 3–10 minutes at high power. A third thermal assault on already-degraded oil. Secondary and tertiary oxidation products (aldol condensation products, alkyl furans, polymerised triacylglycerols) form in significant quantities.

Cycle 4: Post-heating hold time. The meal sits on a plate, in a cooling but still-warm state, with maximum surface area exposed to atmospheric oxygen. The final oxidation window before ingestion.

By the time the consumer eats the meal, the oil has been through three to four thermal oxidation cycles spanning days to weeks. The toxic aldehyde content bears no resemblance to the fresh oil that went into the manufacturing process.

2.3 The Antioxidant Illusion

Synthetic BHT and BHA are added to processed oils at 100–200 parts per million. These concentrations are insufficient to protect high-PUFA oils through multiple heating cycles and extended shelf life. They are regulatory compliance measures, not biochemical protection.

Some manufacturers add “vitamin E” to product labels. This synthetic dl-alpha-tocopherol is added post-processing. It does not protect the oil matrix during cooking, because it was not present during cooking. By the time the consumer opens the package, the oil has already been oxidised through three thermal cycles. The label vitamin is marketing. It has no functional relationship to the oxidative state of the product.

2.4 Quantifying the Exposure

A single ready meal delivers approximately 15–25g of oil that has undergone multiple thermal oxidation cycles. For a consumer eating five to ten ready meals per week (a common pattern in UK households with shift workers, single occupants, and time-poor families), the weekly intake of oxidised seed oil ranges from 75–250g.

Each gram of this oil contains measurable concentrations of 4-HNE, MDA, acrolein, hexanal, 2,4-decadienal, and polymerised compounds.⁵ The total weekly toxic aldehyde load from ready meals alone, before accounting for cooking oils, snacks, cereals, and biscuits, creates a chronic oxidative burden that exceeds the capacity of endogenous antioxidant systems in anyone with marginal vitamin E or selenium status.

In the UK population, marginal vitamin E status is not the exception. It is approaching the norm. Average vitamin E intake from food falls below the RDA in multiple survey datasets. Soil selenium levels across much of England and Wales are classified as low. The antioxidant buffer that separates chronic subclinical lipid peroxidation from functional capillary disturbance is thinner than most clinicians recognise.

Part Three: Fast Food Frying and the Traditional Chip Shop

3.1 Fish and Chips: The Traditional Exposure

UK fish and chip shops have largely transitioned from beef dripping and palm oil to rapeseed oil blends, driven by cost pressures and health messaging that promoted seed oils over saturated fats. The cooking conditions:

ParameterSpecificationTemperature180–190°COil turnover Variable, 1–7 days before replacement Food matrix High-protein battered fish, starch batter, thick-cut potato chips Oxidation state at service Moderate (peroxide value 20–40 mEq O₂/kg)

Primary thermal degradation products at these temperatures include 4-hydroxy-2-hexenal (4-HHE, specific to omega-3 PUFA oxidation), 4-hydroxy-2-nonenal (4-HNE, from omega-6 oxidation), acrolein, malondialdehyde (MDA), and highly reactive 2,4-alkadienals.⁵⁶

A single fish and chip meal delivers an estimated 30–50g of absorbed oil. The dose is substantial, but intermittent consumption (weekly or monthly) allows the body’s glutathione reserves to regenerate and vitamin E levels to recover between exposures. The damage accumulates over decades.

3.2 High-Volume Fast Food Chains: Continuous Thermal Cycling

Major global fast food chains operating continuous deep-frying operations work under a fundamentally different oil regime:

ParameterSpecificationTemperature160–175°C (fries), 175–185°C (coated products)Oil regime Filtered daily, heated 12–18 hours per day, reused for multiple days Heating cycles per oil batch Estimated 50–100 or more Food surface area Extremely high (thin-cut fries maximise oil absorption per gram)

The repeated heating effect is where the chemistry separates high-volume continuous frying from a traditional chip shop. Published research documents significant increases in hexanal and other volatile aldehydes in thermally cycled oils compared to fresh oil.⁴ Peroxide values peak then decline as peroxides decompose faster than they form. This decline is not improvement. It means primary oxidation products are converting into secondary toxic aldehydes faster than new peroxides can accumulate. The oil is not stabilising. It is moving into a more advanced degradation state.

Vitamin E content drops substantially within the first hours of continuous heating.⁴ After multiple days of intermittent use, PUFA content decreases measurably because the polyunsaturated fatty acids have been destroyed by oxidation, converted into the toxic degradation products that now saturate the oil matrix.

4-HNE formation shows gradual, cumulative increase with continuous thermal exposure.⁵ In pre-oxidised oil (oil that has already been used for days), brief heating produces equivalent aldehyde concentrations to significantly longer periods in fresh oil. The starting point for each frying cycle is worse than the last.

Alkyl furans (2-pentylfuran and 2-ethylfuran) show continuous increase in repeatedly heated oil. These compounds form via intramolecular cyclisation of 2-alkenals at temperatures above 160°C and are markers of advanced lipid oxidation that do not appear in single-use oil.⁴ Their presence in continuously cycled fryer oil is a chemical signature of thermal abuse.

Polar compound levels approach or exceed the 25% threshold (the legal limit in many EU countries) after several days of continuous use.⁷ Polymerised triacylglycerols increase oil viscosity, reduce heat transfer efficiency, and when consumed, form compact deposits in capillary walls.

3.3 Direct Comparison

The following table presents measured values from published literature where cited and author estimates (marked *) based on published degradation curves where direct measurement data for the specific commercial context is unavailable.

Factor Traditional Chip Shop High-Volume Continuous Frying Oxidation state at service Moderate (single-day heating)Advanced (continuous thermal cycling)4-HNE concentration Lower range*Estimated 2–3× higher*Acrolein concentration~150mg/kg⁶Higher (glycerol decomposition plus lipid oxidation)*Vitamin E remaining in oil40–60% of original⁴10–20% of original*Aldol condensation products Minimal (early-stage oxidation)Significant*Alkyl furans Low (2-pentylfuran detectable)⁴High (continuous formation, advanced oxidation marker)Polar compounds Below 25% EU threshold Approaching or exceeding 25% threshold⁷Consumption frequency Weekly or monthly Daily or multiple times daily Recovery window6–7 days (adequate for glutathione regeneration)24 hours (insufficient for full antioxidant repletion)Estimated timeline to clinical effect10–20 years with regular consumption*Accelerated with daily consumption*

The continuous thermal cycling method produces a more degraded oil product, consumed more frequently, with insufficient recovery time between exposures, resulting in an accelerated oxidative burden compared to intermittent chip shop consumption.

3.4 The Biological Impact Chain

Research on animals fed repeatedly heated vegetable oils documents the downstream consequences: significantly elevated liver and serum MDA, reduced glutathione peroxidase activity, arterial pressure elevation, cardiac muscle changes, altered aortic smooth muscle response, and elevated DNA damage markers (8-OHdG) in Comet assays.⁸ Plasma levels of LDH, CPK, and homocysteine increase significantly.

These are not subtle laboratory findings. They describe systemic vascular and oxidative damage from chronic consumption of the same oils used in commercial food preparation.

Part Four: The Cereal and Biscuit Problem

4.1 The Duck Feed Observation

During a separate investigation into UK poultry feed formulations, a direct observation was documented: ducks exposed to a suspect commercial feed showed character change, aggression, and loss of normal behaviour within 24 hours of feed substitution.⁹ These were not my ducks. Their characters were gone.

This observation was not anecdotal noise. It was biochemically consistent with Wolf and Pappenheimer’s finding that extreme changes could develop within six hours. The suspect feed contained high-linolenic rapeseed and linseed oil with marginal vitamin E (0.1mg/kg selenium versus the 0.25mg/kg the birds were adapted to) and likely pre-oxidised oil from processing, storage, and hopper exposure.

The observation raised an immediate question: what human food products share this exact composition profile?

4.2 Breakfast Cereals and Biscuits: The Daily Dose

The answer is breakfast cereals and biscuits, consumed daily by millions, including children with developing brains, on empty stomachs for maximum absorption.

Parameter Typical UK Cereal or Biscuit (2024–2026)Primary fat source Rapeseed/sunflower/palm blend (often listed as “vegetable oils”)Linoleic acid content3–8g per 40g serving Vitamin E (label claim)”Added” or “fortified” Actual antioxidant protection at point of consumption Marginal to none Processing method Extrusion cooking (120–180°C, 20–40 bar pressure, extreme mechanical shear)Shelf life6–12 months ambient storage Sugar content10–40% by weight

4.3 Extrusion: Worse Than Frying

Extrusion cooking subjects oil to temperatures of 120–180°C, pressures of 20–40 bar, and extreme mechanical shear simultaneously. This is not comparable to frying. The triple stress of heat, pressure, and shear generates lipid oxidation rates beyond anything that simple thermal exposure produces.

The combination destroys native tocopherols before any “fortification” vitamins are added. It produces elevated 4-HNE, MDA, and acrolein. It creates polymerised triacylglycerols that increase product stability on the shelf while delivering compounds that form deposits in human capillary walls.

Deep frying subjects oil to high temperatures at atmospheric pressure. Extrusion subjects oil to high temperatures at high pressure with mechanical shearing. Gram for gram of oil, extrusion generates more toxic aldehydes than frying. The product then sits on a shelf for months, continuing to oxidise, before the consumer opens the packet.

4.4 The Fortification Illusion

Many cereals and biscuits carry labels stating they contain added vitamin E or are fortified with antioxidants. This creates a perception of protection that is biochemically false:

The oil matrix is oxidised during extrusion processing, before the synthetic vitamin is added. Synthetic dl-alpha-tocopherol is added after the damage is done. It does not retroactively un-oxidise the lipids. The added vitamins degrade during the 6–12 month shelf storage period, particularly in a high-PUFA matrix that continuously generates free radicals.

The consumer reads “fortified with vitamin E” and believes the product protects their health. The product delivers pre-oxidised lipids with marginal functional antioxidant capacity. The label claim and the biochemical reality occupy different universes.

4.5 The Sugar Multiplier

Cereals and biscuits typically contain 10–40% sugar by weight. This is not incidental to the encephalomalacia pathway. It accelerates it through three mechanisms:

First, insulin spikes from rapid carbohydrate absorption increase mitochondrial reactive oxygen species production. The endothelium, already under assault from circulating lipid peroxides, faces a second oxidative hit from within the cells it serves.

Second, hyperglycaemia impairs endothelial nitric oxide production. Nitric oxide is the primary regulator of capillary vasomotor tone. Without adequate nitric oxide, capillaries lose their ability to dilate and constrict appropriately. This compounds the functional circulatory disturbance that Wolf and Pappenheimer identified as the initiating event in encephalomalacia.

Third, advanced glycation end-products (AGEs) form from sugar reacting with oxidised lipids and proteins. AGEs are pro-inflammatory and pro-oxidant, creating a self-amplifying cycle: oxidised oil damages cells, sugar generates AGEs that damage more cells, and the antioxidant system, already depleted by the oil, cannot maintain pace.

A cereal or biscuit meal delivers a triple hit: oxidised PUFA lipids causing endothelial swelling, a sugar spike driving mitochondrial oxidative stress and impairing nitric oxide, and marginal antioxidant protection providing no meaningful defence against either.

4.6 Why Cereals and Biscuits Are the Worst Offender

Risk Factor High-Volume Fast Food Frying Cereals and Biscuits Thermal oxidation per gram oil High (frying, repeated heating)Very high (extrusion plus shear plus 6–12 month shelf oxidation)Consumption frequency Variable Daily, often multiple times daily Target vulnerability General population Developing brains (children)Perception of safety ”Treat” or “indulgence” “Healthy,” “fortified,” “whole grain” Timing of absorption Variable Empty stomach, first meal, maximal up take Duration of exposure Years if habitual Years starting in early childhood Sugar compounding Variable Built into the product at 10–40%

The worst-case scenario: a child consuming a high-PUFA, high-sugar, “fortified” cereal every morning for years, with marginal dietary antioxidant intake, genetically susceptible to oxidative stress (TTPA variant, APOE4 carrier), living in a selenium-depleted region of the UK.

The clinical outcome: accelerated timeline to functional capillary dysfunction, regional micro-ischemia, neuro behavioural decline, a clinical label (ADHD, anxiety, learning difficulty, “behavioural problems”), and pharmacological management that addresses the symptoms without investigating the upstream metabolic driver.

4.7 The 24-Hour Parallel

The ducks changed character in 24 hours. Could a human child experience measurable neuro behavioural change after acute high-PUFA, high-sugar, low-antioxidant exposure?

Biochemically, the pathway supports it:

Hours 0–4 post-consumption: rapid absorption of oxidised lipid peroxides from small intestine (enhanced by empty stomach). Circulating 4-HNE, MDA, and acrolein integrate into erythrocyte and endothelial membranes. Hepatic vitamin E reserves consumed neutralising incoming peroxides.

Hours 4–12: functional vasomotor instability in vulnerable brain regions (limbic system, prefrontal cortex, cerebellum). Subtle neuro behavioural shifts: irritability, reduced attention span, emotional lability.

Hours 12–24: if the meal is repeated (next breakfast), the cycle compounds without full antioxidant recovery. Glutathione reserves not fully regenerated. Behavioural changes become observable.

Paediatric literature documents acute behavioural changes after high-sugar, high-processed-food meals. It documents correlations between dietary PUFA load and ADHD symptom severity. It documents rapid improvement in attention and behaviour when children switch to whole-food, antioxidant-rich diets. The missing link has been mechanistic: why would diet affect behaviour this quickly? Wolf and Pappenheimer’s functional capillary disturbance provides a candidate explanation. This specific timeline remains a proposed mechanism requiring controlled study.

Part Five: Forward-Engineering Neurodegeneration - A Convergence Hypothesis

5.1 The Hypothesis

What follows is a hypothesis. It is grounded in documented biochemistry and supported by epidemiological correlation, but it has not been tested as a unified model in controlled human trials. The hypothesis is stated here because it is falsifiable, and Part Nine provides the protocol to test it.

Modern neurobiology increasingly recognises that historically distinct neurodegenerative labels may represent regional expressions of shared upstream biochemical pathways, differentiated by vascular architecture, genetic susceptibility, and diagnostic tradition rather than by fundamentally distinct disease processes.

Using the Wolf and Pappenheimer pathway, the forward-engineering model runs:

Step Mechanism Human Correlate1. Dietary input High oxidised PUFA plus low vitamin E/selenium plus thermal/repeated oil degradation Industrial seed oils, ultra-processed foods, reheated commercial oils, refined carbohydrate matrices2. Systemic biochemistry Lipid peroxidation cascade, vitamin E/selenium depletion, endothelial swelling, capillary vasomotor dysfunction Elevated F2-isoprostanes, 4-HNE, MDA; reduced glutathione peroxidase activity; microvascular rarefaction3. Functional ischemia Capillary perfusion instability, localised hypoxia, oxidative neuronal injury Same mechanism as chicks: functional circulatory disturbance precedes necrosis4. Regional vulnerability Neurons with high metabolic demand, high membrane PUFA content, or sharp capillary branching angles fail first Hippocampus (Alzheimer’s label), substantia nigra (Parkinson’s label), striatum (Huntington’s acceleration), diffuse white matter (vascular dementia label)5. Clinical label Symptom-based diagnosis assigned before molecular or histopathological differentiation Disease names reflect clinical phenotype, not upstream mechanism

5.2 Disease by Disease

Alzheimer’s Disease: Hippocampal and Cortical Encephalomalacia

Chronic high linoleic acid intake from soybean, corn, and sunflower oils combined with low alpha-tocopherol and refined carbohydrates drives systemic insulin resistance and lipid peroxidation. Oxidised lipids integrate into hippocampal neuronal membranes. Published research demonstrates that 4-HNE, when it reacts with phosphorylated tau protein, promotes conformational changes that generate the major properties defining neurofibrillary tangles in Alzheimer’s brains.¹⁰ Elevated 4-HNE, acrolein, MDA, and F2-isoprostanes have been consistently documented in Alzheimer’s brains compared to age-matched controls.¹¹

Capillary endothelial swelling reduces cerebral blood flow to the hippocampus. The chick model shows edema, then Purkinje cell ischemic necrosis, then microglial activation, then gliosis. Human Alzheimer’s pathology shows early microvascular dysfunction, white matter rarefaction, and reactive gliosis before amyloid plaques dominate the histological picture.

A 2023 review specifically examining the relationship between cooking oil peroxidation products and Alzheimer’s pathology concluded that the amyloid hypothesis has become unreliable based on the failure of anti-amyloid clinical trials, and argued that lipid peroxidation products, particularly 4-HNE, warrant investigation as upstream drivers of the disease process.¹²

Under this hypothesis, the amyloid plaques are debris from the oxidative damage, not the primary cause of it. The pharmaceutical industry has spent decades and billions targeting the wreckage while the fire continued upstream.

Parkinson’s Disease: Substantia Nigra Encephalomalacia

Substantia nigra neurons are uniquely vulnerable to the encephalomalacia pathway: they contain high intrinsic iron levels (which catalyse Fenton reactions that multiply hydroxyl radical production), high polyunsaturated membrane content, and low endogenous catalase and glutathione reserves compared to other brain regions. They are, by design, the first neurons to fail under sustained oxidative assault.

Lipid peroxidation drives mitochondrial Complex I dysfunction, leading to alpha-synuclein aggregation and Lewy body formation. Capillary endothelial swelling with functional vasoconstriction produces localised ischemia. The chick model’s sequence of hyaline thrombi plus edema leading to necrosis maps to nigral microvascular collapse.

The tremor, rigidity, and bradykinesia of Parkinson’s are symptoms of substantia nigra neuron death. The neuron death follows functional ischemia. The functional ischemia follows capillary dysfunction. The capillary dysfunction follows lipid peroxidation. The lipid peroxidation follows dietary PUFA overload with inadequate antioxidant protection.

Vascular and Mixed Dementia: Diffuse Functional Encephalomalacia

This is the closest match to the chick model in clinical practice. Repeatedly heated seed oils combined with trans fats and low vitamin E/selenium drive systemic endothelial dysfunction and capillary hyaline thickening throughout the brain. Wolf and Pappenheimer’s description of edema, rapid necrosis of neural elements, hyaline capillary thrombi, and compound granular cells matches human vascular dementia post-mortem findings with remarkable precision.

“Mixed dementia,” now the dominant autopsy finding in elderly dementia patients, describes overlapping vascular and neurodegenerative pathology. This is exactly what the encephalomalacia model predicts: diffuse capillary dysfunction damages multiple brain regions simultaneously, producing a clinical picture that does not fit neatly into any single diagnostic category.

Huntington’s Disease: Genetic Vulnerability, Dietary Acceleration

Huntington’s disease has a clear genetic cause: autosomal dominant HTT CAG repeat expansion. Diet does not cause Huntington’s. But diet may modify onset age and progression velocity. Mutant huntingtin impairs mitochondrial trafficking and antioxidant response in striatal medium spiny neurons. High-PUFA, low-antioxidant diets would multiply lipid peroxidation in these already-vulnerable cells, potentially accelerating excitotoxicity and caspase activation. The same ischemic-encephalomalacic pathway applies, but genetic vulnerability shifts the anatomical target and lowers the threshold for damage.

5.3 Why Different Names for the Same Pathway

The same question has been answered before in medical history.

Beriberi, pellagra, and scurvy were once classified as separate diseases with complex, mysterious causes. The vitamin deficiency pathway unified them. “Dropsy” was a symptom diagnosis until heart failure, kidney failure, and liver disease were differentiated by mechanism rather than by the shared endpoint of fluid retention.

Neurodegeneration may be undergoing the same convergence. The labels Alzheimer’s, Parkinson’s, vascular dementia, and mixed dementia were created when clinicians could observe symptoms but not mechanisms.

Now that upstream mechanisms are documented, the labels look increasingly like geographic descriptions of the same flood: the hippocampal district was inundated, so we call it Alzheimer’s; the nigral quarter went under, so we call it Parkinson’s; the whole town flooded, so we call it mixed dementia.

The water level rose because the same river overflowed.

The hypothesis: the river is lipid peroxidation from chronic PUFA overload with inadequate antioxidant protection.

Part Six: The Historical Dietary Timeline

6.1 The Shift

Era Dietary Pattern Biochemical Consequence Neurological Outcome Pre-1950sAnimal fats, butter, olive oil, whole grains, adequate vitamin E and selenium from soil and forage Stable membrane lipids, intact glutathione peroxidase, minimal lipid peroxidation Low neurodegenerative prevalence; cognitive decline attributed to “senility”1950s–1970sIndustrial seed oils replace saturated fats; refining strips tocopherols; hydrogenation introduced Rising omega-6:omega-3 ratio; first generation of oxidised lipid exposure; antioxidant gap begins Early rise in vascular dementia; Parkinson’s incidence increases with age1980s–1990s”Low-fat” guidelines drive massive PUFA substitution; margarine, processed snacks, restaurant frying culture expandOmega-6:omega-3 ratio reaches 15:1–20:1; repeated oil heating generates 4-HNE, acrolein, MDA; vitamin E intake falls below RDA Alzheimer’s prevalence surges post-1990s; dementia becomes leading cause of elderly mortality in developed nations2000s–2020sUltra-processed foods dominate; delivery and reheated oils; soil selenium depletion; marginal antioxidant intake Chronic systemic lipid peroxidation; capillary endothelial dysfunction; microvascular rarefaction Parkinson’s, Alzheimer’s, vascular dementia diagnoses merge clinically; “mixed dementia” becomes dominant autopsy finding2022–2026Ukraine conflict triggers mass oil substitution: sunflower to rapeseed across UK and EU; rapeseed with 9–11% linolenic acid enters products that previously used more stable blends Further increase in dietary PUFA oxidation potential; vitamin E margins further compressed Projected dementia rate increase; early-onset cognitive decline cases rising

6.2 The 15–20 Year Lag

The temporal gap between dietary shift and clinical manifestation appears to be approximately 15–20 years. This is consistent with the Wolf and Pappenheimer observation that acute exposure can produce cerebellar lesions within hours, but chronic sub-acute exposure in a species with greater compensatory reserves requires years to exhaust those reserves.

Human brains are not defenceless. Hepatic alpha-tocopherol transfer protein preferentially retains vitamin E in circulation. Glutathione reserves can be regenerated. Uric acid, bilirubin, and vitamin C provide secondary antioxidant cover. These systems buy time. They do not buy immunity.

When the dietary assault is daily, for years, with marginal antioxidant intake, the buffer erodes. The point at which compensatory mechanisms are overwhelmed is individual, determined by genetics, age, comorbidities, and the precise balance of dietary exposure versus antioxidant capacity. But in a population exposed to the same processed food supply, the average time from exposure to clinical manifestation appears to cluster around 15–20 years.

This observed pattern would explain why the dietary changes of the 1980s produced the dementia epidemic of the 2000s. It also suggests the consequences of the post-2022 rapeseed oil substitution will not fully manifest until the late 2030s and 2040s.

6.3 North American Baseline

In 1900, seed oils represented approximately 1% of added fat in the American diet. By 2020, ultra-processed foods accounted for approximately 58% of American calories.¹³¹⁴ The dementia burden grew in parallel with this substitution, offset by the expected lag period.

Blasbalg and colleagues reconstructed US fatty acid consumption from 1909 to 1999, documenting that linoleic acid intake rose from 2.79% of total calories to 7.21% — a 158% increase — while per-capita soybean oil consumption rose more than a thousand fold over the same period.¹³

Part Seven: The Global Processed Food Rollout

7.1 Market Expansion and Neurological Burden

The expansion of processed food brands into new markets provides a natural experiment in population-level oxidative injury. Regions that adopted Western-style processed foods later show steeper rises in age-standardised neurological disease, compressed into shorter timescales.

United Kingdom and Western Europe: Dementia prevalence across the EU27 is now estimated at over 9 million people.¹⁵ UK ultra-processed food consumption accounts for approximately 57% of total caloric intake.¹⁴ A prospective cohort study following 10,775 participants over a median of 8 years found that consumption of ultra-processed food above 19.9% of daily calories was associated with a 28% faster rate of global cognitive decline.¹⁶

Asia-Pacific: The Asia-Pacific processed biscuit and snack market is growing at compound annual rates exceeding 6%. East Asia and Pacific regions show among the highest Parkinson’s prevalence globally. Age-standardised Alzheimer’s rates in Japan and China are among the world’s highest and continue to rise.

India: Mass-market processed biscuit brands entered the Indian market in the early 1990s. India’s biscuit consumption has expanded with urbanisation. Parkinson’s prevalence shows progressive increase in community studies. The lag from mass adoption (mid-1990s) to emerging data (2020s) is approximately 25 years.

In each case, the timeline from processed food adoption to neurological disease rise follows the same approximate 15–20 year pattern, compressed where adoption was more rapid.

7.2 The Health Halo Paradox

Many biscuits and cereals carry “fortified with vitamins” or “whole grain” labels. These claims create a perception of safety that increases consumption frequency and duration. The health halo does not reduce the toxic aldehyde content. It increases exposure. Heritage-branded digestive biscuits imply digestive health. Energy-branded breakfast biscuits imply morning vitality. Traditional tea biscuits imply harmlessness. The branding has no relationship to the oxidative state of the product.

Part Eight: The Diagnostic Gap

8.1 What Clinicians Do Not Test

Standard neurological workup for cognitive decline includes brain imaging, cognitive testing, blood glucose, thyroid function, and vitamin B12. It does not include:

• Serum alpha-tocopherol (lipid-adjusted)

• Erythrocyte glutathione peroxidase activity

• Plasma F2-isoprostanes

• 4-HNE levels

• MDA levels

• Omega-6:omega-3 ratio

• Whole blood selenium status

Without these measurements, nutritional encephalomalacia is invisible to the diagnostic process. The clinician observes the downstream damage and assigns a label. The upstream metabolic cause is never investigated because the tests are never ordered.

8.2 Diagnostic Label Inertia

Once a label is assigned, the system reinforces it. Research funding flows to amyloid, tau, or alpha-synuclein hypotheses. Clinical trials test monoclonal antibodies, not antioxidant repletion. Pharmaceutical revenue depends on chronic disease management, not dietary correction. The upstream metabolic cause remains un- investigated because investigating it would require restructuring research priorities, clinical protocols, and pharmaceutical pipelines simultaneously.

This is not conspiracy. It is institutional momentum. The labels were created before the mechanisms were understood. The mechanisms are now documented. The labels persist.

Part Nine: Verification Protocol

9.1 Biomarker Testing

Baseline panel: Serum alpha-tocopherol (lipid-adjusted), selenium (whole blood), erythrocyte glutathione peroxidase activity, plasma F2-isoprostanes, 4-HNE, MDA, omega-6:omega-3 ratio.

Intervention (6-month protocol): Complete elimination of ready meals, ultra-processed foods, and repeatedly heated seed oils. Targeted repletion: vitamin E 400 IU per day (mixed tocopherols), selenium 200mcg per day, omega-3 EPA/DHA 2g per day. Replace seed oils with stable fats (olive oil, butter, coconut oil, beef dripping).

Expected outcome: 40–60% reduction in lipid peroxidation markers, clinical symptom stabilisation or improvement.

9.2 Neuroimaging

Perfusion MRI to quantify cerebral blood flow before and after intervention. Susceptibility-weighted imaging to detect microhaemorrhages from capillary fragility. MR spectroscopy to measure neuronal integrity markers (NAA/Cr ratio).

9.3 Histopathological Cross-Reference

Compare human dementia brain sections with Wolf and Pappenheimer’s chick encephalomalacia material. Expected match: edema, Purkinje cell ischemic necrosis, hyaline capillary thrombi, compound granule cells, gliosis. Expected absence: viral inclusion bodies, perivascular lymphocytic cuffing.

This comparison has, to date, never been formally conducted.

9.4 Product Analysis

Submit samples of suspect ready meals, cereals, and biscuits to independent laboratory for peroxide value (oil oxidation status), actual versus label vitamin E content, PUFA profile (linoleic and linolenic acid quantification), and aldehyde content (4-HNE, MDA via HPLC).

Part Ten: The Equations

Ready meal plus time equals encephalomalacia.

Fast food plus frequency equals accelerated encephalomalacia.

Breakfast cereal plus childhood equals developmental encephalomalacia.

These are not metaphors. They are biochemical statements grounded in documented pathways:

• High-PUFA seed oil content (rapeseed, sunflower, linseed)

• Marginal antioxidant protection (vitamin E, selenium stripped or absent)

• Repeated thermal oxidation (industrial processing plus consumer reheating)

• Chronic daily consumption over years to decades

• Individual susceptibility (genetic, age, comorbidities, selenium status)

Wolf and Pappenheimer proved the mechanism in 1931. The UK feed investigation documented it operating in poultry in 2026. Human neurodegenerative disease incidence is consistent with it operating in people. The epidemiological data from every continent where processed food has expanded is consistent with the 15–20 year lag from dietary shift to clinical manifestation.

The only variable is diagnostic recognition. Until clinicians test for lipid peroxidation, measure antioxidant status, and include nutritional encephalomalacia in differential diagnosis for adult-onset neurological disease, ready meals will continue producing ready encephalomalacia.

And we will continue to call it Alzheimer’s, Parkinson’s, and dementia.

The pathway is documented. The mechanism is conserved. The outcome is predictable. The hypothesis is falsifiable. Test it.

References

Independent Investigation. WattyAlan Reports, May 2026. Adam White. All sources from public record as of May 2026.

Footnotes

1. Wolf, A. and Pappenheimer, A.M. (1931). “The Histopathology of Nutritional Encephalomalacia of Chicks.” Journal of Experimental Medicine, 54(3), 399–405. doi:10.1084/jem.54.3.399. Columbia University, New York. ↩ ↩²

2. Pappenheimer, A.M. and Goettsch, M. (1931). “A cerebellar disorder in chicks, apparently of nutritional origin.” Journal of Experimental Medicine, 53, 11–26. doi:10.1084/jem.53.1.11. Columbia University, New York. ↩

3. Nadeem, M. et al. (2015). Relative autoxidation rates of fatty acids: stearic 1, oleic 100, linoleic 1,200, linolenic 2,500. As cited in: Liu, J. et al. (2023). “Lipid oxidation in food science and nutritional health: A comprehensive review.” Oil Crop Science, 8(1), 1–14. doi:10.1016/j.ocsci.2023.01.002. Original rates derived from methylene bridge index analysis. ↩ ↩²

4. Bogdanovic, A. et al. (2022). “Effects of Repeated Heating on Fatty Acid Composition of Plant-Based Cooking Oils.” Foods, 11(2), 192. doi:10.3390/foods11020192. MDPI. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶

5. Ferraro, V. et al. (2025). “Toxic aldehydes in cooking vegetable oils: Generation, toxicity and disposal methods.” Foods, MDPI. Documents acrolein content of 207.4 mg/kg after 24h at 180°C, and formation profiles of 4-HNE, 4-HHE, MDA, hexanal, and 2,4-decadienal at frying temperatures. ↩ ↩² ↩³ ↩⁴

6. Guillén, M.D. and Uriarte, P.S. (2012). “Simultaneous determination of lipophilic aldehydes by HPLC in vegetable oil.” Documents 4-HHE and 4-HNE formation in sunflower and linseed oils after prolonged heating at frying temperature. ↩ ↩²

7. EU Regulation on polar compounds in frying oils: multiple EU member states enforce a 25% total polar compound limit for commercial frying oil. See national implementations of European food safety standards. ↩ ↩²

8. Jaarin, K. et al. (2012). “Involvement of Inflammation and Adverse Vascular Remodelling in the Blood Pressure Raising Effect of Repeatedly Heated Palm Oil in Rats.” International Journal of Vascular Medicine, 2012, Article 404025. doi:10.1155/2012/404025. ↩

9. Independent feed investigation document, March 2026. WattyAlan Reports. First-hand documented observation. ↩

10. Liu, Q. et al. (2005). “Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations.” Free Radical Biology and Medicine, 38(6), 746–754. doi:10.1016/j.freeradbiomed.2004.11.005. Demonstrated that 4-HNE modification of phosphorylated tau promotes conformational changes generating neurofibrillary tangle epitopes. ↩

11. Butterfield, D.A. and Mattson, M.P. (2020). “Brain lipid peroxidation and Alzheimer disease: Synergy between the Butterfield and Mattson laboratories.” Ageing Research Reviews, 64, 101049. Documents elevated 4-HNE protein adducts, MDA, acrolein, and F2-isoprostanes in AD and MCI brains. ↩

12. Chen, Z. et al. (2023). “Implication of the cooking oil-peroxidation product ‘hydroxynonenal’ for Alzheimer’s disease.” BMC Neurology, 23, 315. Argues the amyloid hypothesis has become unreliable based on clinical trial failures and presents evidence for 4-HNE as an upstream driver of AD pathology. ↩

13. Blasbalg, T.L. et al. (2011). “Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century.” American Journal of Clinical Nutrition, 93(5), 950–962. doi:10.3945/ajcn.110.006643. ↩ ↩²

14. Rauber, F. et al. (2018). “Ultra-Processed Food Consumption and Chronic Non-Communicable Diseases-Related Dietary Nutrient Profile in the UK (2008–2014).” Nutrients, 10(5), 587. doi:10.3390/nu10050587. NDNS analysis showing 56.8% of UK calories from ultra-processed foods. ↩ ↩²

15. Alzheimer Europe. Dementia in Europe Yearbook 2024. Prevalence data. ↩

16. Gonçalves, N.G. et al. (2023). “Association Between Consumption of Ultraprocessed Foods and Cognitive Decline.” JAMA Neurology, 80(2), 142–150. doi:10.1001/jamaneurol.2022.4397. ELSA-Brasil cohort, n=10,775, median follow-up 8 years. ↩

When you understand the controlling mechanisms behind what you see, the moment the shutters let the experience back in, a sense of calm envelops everything you are.

It was not long before they realized the most powerful tool of control was simply headlines.

Thrown at your doorstep by a spotty kid on a Chopper.

Headlines in bold print stir chemicals in the brain, attach themselves to new protein stacks, cement permanent memory of an accepted reality that never existed.

The sound and rhythm of crunching pointless cornflakes that held no value as livestock feed.

“More coffee, honey?”

“Mmm. I see they’re using chemical weapons in Cambodia again.”

Across the dining table, spoken words cemented the lie. The headline became memory. Memory became truth. Truth that never happened, solidified over breakfast, repeated at work, accepted by evening.

No war in Cambodia that morning.

Just ink on paper and chemicals in your brain building a world that served someone else’s agenda.

You lived in their construction. Called it news. Called it reality.

Never questioning why a spotty kid on a bike held more power over your mind than your own eyes ever could.

THE BULLSHIT YOU SWALLOWED

WITH YOUR CORN FLAKES

(America, 1980–1989 — a decade of headlines that built a world that wasn’t there)

1980

“Iran Executed the Hostages — Bodies Recovered”
AP wire, 28 Oct 1980
False. Panic spread before correction. Families collapsed on live TV. The emotional truth stuck — long after the retraction vanished.

1981

“Soviets Behind Air Florida Crash — Sabotage Confirmed”
The Washington Times, Jan 1982 (reported as “intelligence consensus” in Dec ’81 leaks)
False. NTSB: pilot error + ice. But for weeks, Reagan aides floated “foreign hand” to deflect scrutiny from airline deregulation.

1982

“Nicaraguan Sandinistas Massacre 1,200 Contras in Jungle Ambush”
Miami Herald, 17 June 1982
False. Contra “army” numbered ~300 total. Death toll: 7. But the number 1,200 entered Congress testimony — helped pass covert aid.

1983

“Soviet Nuclear Sub Collides with USS Nimitz — Radiological Leak”
UPI, repeated on CNN, 5 April 1983
False. No Soviet sub near Nimitz. Story originated from a Pentagon prank call. Yet DEFCON-3 rumors spread. Calm restored only after 36 hours of silence.

1984

“Cuba Deploying Medium-Range Missiles in Grenada”
New York Times, front page, 24 Oct 1983 (pre-invasion), echoed through 1984 hearings
False. Grenada had construction equipment — misidentified as missile erectors. Key justification for invasion. Later admitted by Pentagon: “inconclusive evidence.”

1985

“Libyan hit squad in US to assassinate Reagan — FBI confirms”
Los Angeles Times, 12 May 1985
False. No such plot. Based on coerced testimony from a jailed informant. Used to justify bombing Libya in ’86 — sold as “preemptive.”

1986

“Soviets Poisoning US Wheat Supply — Ergot Found in Midwest Silos”
Chicago Tribune, 3 Feb 1986
False. Ergot is a natural fungus — levels were normal. But the “Soviet bio-sabotage” theory trended for weeks. Grain futures plunged. Farmers panicked.

1987

“Iran-Contra Arms Ship Seized — 200 Tons of U.S. Missiles Headed to Tehran”
Newsweek, 13 April 1987 (cover: “The Smoking Gun Ship”)
False. The Iran was a decoy — no missiles aboard. Later revealed: staged by Oliver North’s team to control the narrative. Worked: public assumed guilt was proven.

1988

“USS Vincennes Shot Down Iranian Civilian Jet in Self-Defense — No Survivors Expected”
All major networks, 3 July 1988
Technically misleading. Yes, it was “self-defense” — but the jet was climbing, civilian-coded, and Vincennes had entered Iranian waters. The framing erased context — and 290 lives.

1989

“Panama’s Noriega Ordered Killing of American Schoolteacher — Motive: She Saw Drug Lab”
NBC Nightly News, 17 Dec 1989 — hours before invasion
False. Kathy Cabezas was killed in a robbery. No drug lab link. But the story was delivered on cue — turned public outrage into consent for Operation Just Cause.

Independent thinking for independent minds. Join us.

Subscribe now

Introduction: The Living Architecture of Memory

Human memory is not a passive repository of information. It is an active, dynamic process involving structural changes in neural tissue. Each time we learn, experience, or believe something, the brain physically reorganizes itself through a process known as synaptic plasticity, the strengthening or weakening of connections between neurons.

This process is not metaphorical. It is biological.

Memory formation involves:

1. Neural activation — certain pathways fire in response to experience

2. Long-term potentiation (LTP) — repeated activation strengthens synaptic connections

3. Protein synthesis — structural proteins are created to stabilize these connections into long-term memory

4. Emotional tagging — the amygdala and hippocampus encode the emotional valence of the experience

The result is a physical memory trace, what neuroscientists call an engram, a distributed network of neurons that, when reactivated, produces the subjective experience of remembering.

What is rarely understood outside neuroscience is this:

The brain does not distinguish between “true” and “false” information during memory encoding.

It responds to emotional significance, not factual accuracy.

This has profound implications for how beliefs are formed, maintained, and manipulated.

Memory as Material: The Protein Pillar Model

To understand memory formation in practical terms, imagine each memory as a pillar built from protein bricks.

When you encounter new information:

1. Sensory input enters the brain (visual, auditory, linguistic)

2. Emotional evaluation occurs (Is this important? Threatening? Exciting?)

3. Neurochemical release follows (dopamine, norepinephrine, cortisol)

4. Neural firing patterns activate specific circuits

5. Protein synthesis begins to stabilize the synaptic changes

This process is called consolidation, and it transforms short-term activation into long-term structural change.

The emotional state present during encoding becomes chemically embedded in the memory structure:

• Joy → oxytocin, dopamine → warm, affiliative coding

• Fear → cortisol, norepinephrine → vigilant, threat-associated coding

• Surprise → dopamine surge → salience marking

Once consolidated, the memory exists as a physical structure in the brain — a distributed network of strengthened synapses held together by structural proteins.

This is not storage. This is construction.

The Positive Memory: Truth as Foundation

Consider a person who reads or hears a heartwarming true story — perhaps an account of courage, compassion, or human connection.

The brain:

• Evaluates the story as emotionally significant

• Activates reward and social cognition circuits

• Releases neurochemicals associated with positive affect

• Begins consolidating the memory with a positive emotional signature

A pillar is built. It is coded with warmth, safety, and affiliation.

This memory can be recalled easily and feels good to remember. It may influence future behavior, attitudes, and identity. It becomes part of the person’s narrative about the world.

And because the event was true, the memory aligns with reality.

The False Memory: Emotion Without Event

Now consider the same person encountering a different story, this time false.

Perhaps it is a headline about a crime that never occurred. A scandal fabricated for political gain. A viral image taken out of context. A piece of misinformation designed to provoke outrage.

If the false information triggers emotion, the brain responds identically:

• The amygdala flags it as significant

• Stress neurochemicals are released

• Neural circuits activate

• Protein synthesis begins

• A memory pillar is built

This pillar is coded with:

• Urgency

• Fear

• Anger

• Threat perception

The memory is physically real. The emotional response is biologically real. The neural structure is materially real.

Only the event itself did not occur.

The Correction: Building a Second Pillar

Hours, days, or weeks later, the person encounters a correction:

“The story was false. It did not happen.”

The brain now processes this new information and begins forming a new memory, the memory of the correction.

But here is the critical insight:

The brain does not go back and rewrite the original memory pillar. It does not delete the false memory or strip away its emotional coding.

Instead, it builds a second pillar, one that contains the correction.

While memory reconsolidation can modify existing engrams, it requires deliberate reactivation under safe conditions and does not reliably erase emotional encoding.

Now the person has:

1. Pillar A: The original false memory (emotionally charged, vivid, consolidated)

2. Pillar B: The correction (often less emotional, less vivid, newer)

Pillar A does not disappear. Its protein structures remain. Its emotional signature persists.

The person may intellectually know the event was false, but the emotional memory remains intact.

Why False Memories Persist

This dual-pillar phenomenon explains several well-documented psychological effects:

1. Belief perseverance — people continue to feel the emotional truth of debunked claims

2. The illusory truth effect — repeated exposure strengthens memory regardless of accuracy

3. Source amnesia — people remember the claim but forget it was false

4. Emotional reasoning — “I feel it’s true” overrides “I know it’s false”

Neuroscientifically, this occurs because:

• Emotional memories are prioritized for retention (evolutionary advantage)

• Reconsolidation is effortful and requires active reprocessing

• The original pillar has a “head start”, it was built first, often with stronger emotion

• The correction competes with, rather than replaces, the false memory

The Mechanism of Influence

This is why control over information, particularly emotionally charged information, translates into control over belief.

If you can trigger emotion, you can build memory.

If you can build memory, you can shape belief.

If you can shape belief, you can influence identity, behavior, and political will.

Over a century ago, those who understood mass communication recognized this principle intuitively. Today, neuroscience has confirmed it materially.

Headlines, narratives, and media frames are not simply “information.” They are biological interventions, tools that physically alter the neural architecture of populations.

Unbuilding the Pillar: The Cost of Correction

Correcting a false belief is not a matter of “changing your mind.” It is a matter of restructuring living tissue.

This requires:

• Repeated exposure to accurate information (to strengthen the new pillar)

• Emotional safety (fear and defensiveness inhibit reconsolidation)

• Cognitive effort (active reprocessing, not passive exposure)

• Time (protein structures degrade slowly)

Even then, the original emotional memory often remains accessible and can be reactivated by contextual cues.

This is why:

• Fact-checking is necessary but insufficient

• Emotional appeals often defeat logical arguments

• Propaganda leaves lasting effects even after exposure

• Personal experience of correction is required (being told is not enough)

Conclusion: Memory, Identity, and Power

We like to think of our memories as “ours”, private, accurate, reflective of what actually happened.

But memory is a construction, not a recording.

It is shaped by emotion, context, repetition, and source.

And because false information can produce real memory structures, the line between truth and belief is not as clear as we assume.

This is not a call to paranoia. It is a call to awareness.

To recognize that:

• We are all vulnerable to emotionally charged misinformation

• Beliefs are not always products of reason

• Changing minds requires more than presenting facts

• Those who consistently shape emotionally salient narratives influence neural encoding at scale.

Your memories are built from experience.

But whose experiences are shaping them?

References & Further Reading

• Hebb, D.O. (1949). The Organization of Behavior. Neuron connectivity and learning theory.

• Kandel, E.R. (2001). The molecular biology of memory storage. Science.

• Loftus, E.F. (1997). Creating false memories. Scientific American.

• Schacter, D.L. (2001). The Seven Sins of Memory. Memory distortion and suggestion.

The living brain, emotional encoding, and the cost of false headlines

Your brain is not a library with empty shelves waiting to be filled. It is alive. It grows.

Every time you learn something, a name, a face, a story, a headline, your brain physically changes itself. New branches grow between neurons.

New connections spark to life. And to lock these pathways into place, your brain builds microscopic structures made from protein.

Think of each memory as a pillar built from protein bricks.

The meaning of that memory is shaped by the chemicals present when it forms:

• If the moment is filled with joy, the pillar is coded with warmth.

• If the moment is stressful, the pillar is coded with alertness and caution.

• If the moment shocks you, the pillar is coded with urgency.

The emotion doesn’t just accompany the memory. It becomes part of its physical structure.

So your memories are not simply “information stored somewhere.” They are:

• Physical

• Living tissue

• Emotionally encoded

• Unique to your experience

Your memories are made of you.

The Positive Anchor

Let’s say you read a beautiful, true story. Something that lifts you. Something that warms your chest and makes you breathe a little deeper.

Your brain builds a pillar for that memory.

It is solid. It is warm. It feels good to remember.

It lives in you.

The Emotional Contrast

Now, on another day, you read something upsetting. Something worrying. Something that hits your nervous system like a shock, bad news, a scandal, a threat.

Your brain reacts the same way:

It builds a pillar.

This one is coded with:

• Urgency

• Fear

• Tension

• Readiness

You feel it differently. But it is just as real.

The Pivot

Now imagine that later, hours, days, or weeks later, you learn:

The upsetting event never actually happened.

The story was false. The headline was misleading. The scandal was manufactured.

You now build another pillar, the new information, the correction.

But here is the critical part:

You are not rewriting the original pillar.

The first memory, the emotional one, remains in place.

The protein bricks are still there. The emotional coding is still active.

The “false” memory stays physically real, even though the event itself was not.

This is how:

• A false headline

• A misunderstanding

• A rumor

• A manipulated narrative

Can become a real emotional memory inside a person.

The Magnitude

The memory of the false event is real.
The emotion is real.
The brain structure holding it is real.

Only the event itself did not occur.

And this is why changing beliefs is so hard:

You are not correcting “a thought.” You are unbuilding a pillar.

You are asking the brain to disassemble living tissue and rebuild itself.

That takes:

• Time

• Safety

• Repetition

• And emotional willingness

Which is precisely why those who control emotional information,

the headlines, the narratives, the triggers, have immense influence.

If they can make you feel,

they can make you remember.

And if they can make you remember,

they can shape what you believe is reality.

This piece is based on established neuroscience research into

memory consolidation, synaptic plasticity, and the role of emotional encoding in long-term memory formation.

For a deeper academic exploration, read the full report.

Part 1b. Are Your Memories Yours? Memory consolidation, emotional encoding, and the neuroscience of false belief formation

Part 2a. Intervention, Prevention and Reversal of False Memory Consolidation

Part 2b. THE MEMORY BYPASS PROTOCOL, A step-by-step method for reconstructing false memories and building cognitive resilience.

Subscribe now

Share